Research: Simplified guidelines for prescribing medical cannabinoids in primary care, Canadian Family Physician

The new 2018 guideline, published in the official journal of the College of Family Physicians of Canada, suggests that clinicians could consider medical cannabinoids only for refractory neuropathic pain and refractory pain in palliative care, chemotherapy-induced nausea and vomiting, and spasticity in multiple sclerosis and spinal cord injury after reasonable trials of standard therapies have failed.

Research: Cannabinoids used in sequence with chemotherapy are a more effective treatment for cancer, International Journal of Oncology (May 2017)

  • A 2017 study on cells from researchers at St. George’s University in London and published in the International Journal of Oncology suggests that using cannabinoids alongside chemotherapy may be a more effective treatment for killing cancer cells than using chemotherapy alone. Furthermore, this research suggests that using cannabinoids alongside chemotherapy could achieve the same anticancer effect with a lower dose of chemotherapy. Summary here.